116 related articles for article (PubMed ID: 18823279)
41. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani.
Roy A; Ganguly A; BoseDasgupta S; Das BB; Pal C; Jaisankar P; Majumder HK
Mol Pharmacol; 2008 Nov; 74(5):1292-307. PubMed ID: 18703668
[TBL] [Abstract][Full Text] [Related]
42. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of in vitro macrophage digestion capacity by infection with Leishmania donovani (Protozoa: Kinetoplastida).
Kutish GF; Janovy J
J Parasitol; 1981 Aug; 67(4):457-62. PubMed ID: 7264834
[TBL] [Abstract][Full Text] [Related]
44. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
[TBL] [Abstract][Full Text] [Related]
45. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
Mukhopadhyay S; Sen P; Majumder HK; Roy S
J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
[TBL] [Abstract][Full Text] [Related]
46. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani.
Ray S; Majumder HK; Chakravarty AK; Mukhopadhyay S; Gil RR; Cordell GA
J Nat Prod; 1996 Jan; 59(1):27-9. PubMed ID: 8984149
[TBL] [Abstract][Full Text] [Related]
47. An experimental challenge model for Leishmania donovani in beagle dogs, showing a similar pattern of parasite burden in the peripheral blood and liver.
Konno H; Yokoyama N; Tamura Y; Aoshima K; Nakao R; Takiguchi M; Katakura K
Parasitol Res; 2022 Dec; 121(12):3569-3579. PubMed ID: 36222954
[TBL] [Abstract][Full Text] [Related]
48. N-terminal region of the large subunit of Leishmania donovani bisubunit topoisomerase I is involved in DNA relaxation and interaction with the smaller subunit.
Das BB; Sen N; Dasgupta SB; Ganguly A; Majumder HK
J Biol Chem; 2005 Apr; 280(16):16335-44. PubMed ID: 15711017
[TBL] [Abstract][Full Text] [Related]
49. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect.
Chauhan IS; Marwa S; Rao GS; Singh N
Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038
[TBL] [Abstract][Full Text] [Related]
50. Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase.
Manhas R; Gowri VS; Madhubala R
J Biol Chem; 2016 Jan; 291(3):1203-20. PubMed ID: 26586914
[TBL] [Abstract][Full Text] [Related]
51. Mevalonate kinase of Leishmania donovani protects parasite against oxidative stress by modulating ergosterol biosynthesis.
Shafi MT; Bamra T; Das S; Kumar A; Abhishek K; Kumar M; Kumar V; Kumar A; Mukherjee R; Sen A; Das P
Microbiol Res; 2021 Oct; 251():126837. PubMed ID: 34375804
[TBL] [Abstract][Full Text] [Related]
52. Anti-parasite activity of nucleoside analogues: the metabolism of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani and its activity against amastigotes of Leishmania donovani in vitro.
Wataya Y; Satake H; Hiraoka O; Aji T; Morishige K; Kimura JY; Ishii A; Matsuda A; Ueda T; Fukukawa K
Nucleic Acids Symp Ser; 1986; (17):149-51. PubMed ID: 3562260
[TBL] [Abstract][Full Text] [Related]
53. Development of derivatives of 3, 3'-diindolylmethane as potent Leishmania donovani bi-subunit topoisomerase IB poisons.
Roy A; Chowdhury S; Sengupta S; Mandal M; Jaisankar P; D'Annessa I; Desideri A; Majumder HK
PLoS One; 2011; 6(12):e28493. PubMed ID: 22174820
[TBL] [Abstract][Full Text] [Related]
54. A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death.
Vergnes B; Gourbal B; Girard I; Sundar S; Drummelsmith J; Ouellette M
Mol Cell Proteomics; 2007 Jan; 6(1):88-101. PubMed ID: 17050524
[TBL] [Abstract][Full Text] [Related]
55. Resistance mechanism development to the topoisomerase-I inhibitor Hoechst 33342 by Leishmania donovani.
Marquis JF; Hardy I; Olivier M
Parasitology; 2005 Aug; 131(Pt 2):197-206. PubMed ID: 16145936
[TBL] [Abstract][Full Text] [Related]
56. Leishmania donovani Internalizes into Host Cells via Caveolin-mediated Endocytosis.
Kumar GA; Karmakar J; Mandal C; Chattopadhyay A
Sci Rep; 2019 Sep; 9(1):12636. PubMed ID: 31477757
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive proteomics analysis of glycosomes from Leishmania donovani.
Jamdhade MD; Pawar H; Chavan S; Sathe G; Umasankar PK; Mahale KN; Dixit T; Madugundu AK; Prasad TS; Gowda H; Pandey A; Patole MS
OMICS; 2015 Mar; 19(3):157-70. PubMed ID: 25748437
[TBL] [Abstract][Full Text] [Related]
58. The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice.
Chowdhury S; Mukherjee T; Mukhopadhyay R; Mukherjee B; Sengupta S; Chattopadhyay S; Jaisankar P; Roy S; Majumder HK
EMBO Mol Med; 2012 Oct; 4(10):1126-43. PubMed ID: 23027614
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.
Sengupta T; Mukherjee M; Das R; Das A; Majumder HK
Nucleic Acids Res; 2005; 33(8):2364-73. PubMed ID: 15860773
[TBL] [Abstract][Full Text] [Related]
60. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites.
Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C
Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
